Advertisement

Ads Placeholder
Loading...

Bayer AG

BAYRY•PNK
Healthcare
Drug Manufacturers - General
$11.39
$-0.21(-1.83%)
U.S. Market is Open • 15:38

Bayer AG (BAYRY) Stock Overview

Explore Bayer AG’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap44.2B
P/E Ratio-10.72
EPS (TTM)$-1.06
ROE-0.12%
Fundamental Analysis

AI Price Forecasts

1 Month$11.09
3 Months$19.01
1 Year Target$13.28

BAYRY Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Bayer AG (BAYRY) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 46.38, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $13.28.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -10.72 and a market capitalization of 44.2B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-2.95%
5-Day Change
2.83%
1-Month Change
2.64%
3-Month Change
1.53%
6-Month Change
33.73%
Year-to-Date (YTD) Change
1.53%
1-Year Change
91.82%
3-Year Change
-30.36%
5-Year Change
-29.98%
All-Time (Max) Change
982.69%

Contact Information

https://www.bayer.com
49 214 30 1
Kaiser-Wilhelm-Allee 1, Leverkusen, NaN, 51368

Company Facts

905,870 Employees
IPO DateNov 18, 1996
CountryDE
Actively Trading

Frequently Asked Questions